Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

Date: December 10, 2014
Pages: 23
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CE3F3E436A3EN
Leaflet:

Download PDF Leaflet

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update
Summary

Calypte Biomedical Corporation (Calypte) is a diagnostic service provider. The company carries out development, manufacturing and marketing of in-vitro testing algorithms for improved diagnosis of HIV infection and other chronic diseases. Its products include rapid tests and traditional EIA diagnostic tests, Aware BED EIA, Aware BED EIA DBS Control Pack, Sampling systems and Aware Messenger. The company provides antigens and recombinant proteins along with proprietary reagents, buffers, and other specialty products for the enhancement of immuno-diagnostic assays. It has manufacturing facilities in the US, Thailand, and China. Calypte is headquartered in Portland, Oregon, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Calypte Biomedical Corporation
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Calypte Biomedical Corporation Company Snapshot
Calypte Biomedical Corporation Company Overview
Key Information
Calypte Biomedical Corporation Pipeline Products and Clinical Trials Overview
Calypte Biomedical Corporation – Pipeline Analysis Overview
Key Facts
Calypte Biomedical Corporation - Major Products and Services
Calypte Biomedical Corporation Pipeline Products by Development Stage
Calypte Biomedical Corporation Pipeline Products Overview
Aware - Syphilis Assay
Aware - Syphilis Assay Product Overview
Aware 2 HIV-1/2
Aware 2 HIV-1/2 Product Overview
Aware HIV-1/2 OMT
Aware HIV-1/2 OMT Product Overview
Second Generation Incidence Test - HIV-1
Second Generation Incidence Test - HIV-1 Product Overview
Calypte Biomedical Corporation - Key Competitors
Calypte Biomedical Corporation - Key Employees
Calypte Biomedical Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Calypte Biomedical Corporation, Recent Developments
Mar 02, 2011: Calypte Biomedical Announces Successful Conclusion Of Internal Trials Of Aware HIV-1/2 Oral Fluid Rapid Test
Dec 04, 2009: Calypte Reports Q3 2009 Results
Oct 08, 2009: Calypte Reports Q2 2009 Results
Sep 25, 2009: Calypte Announces Board Changes
Aug 07, 2009: Calypte Reports Q1 2009 Results
Apr 27, 2009: Calypte Posts Net Loss Of $9.1 Million In 2008
Mar 19, 2009: Calypte Announces Management Changes
Nov 14, 2008: Calypte Declares 3Q 2008 Results
Oct 13, 2008: Calypte Wins Sales Order From LifeLine
Jun 18, 2008: Calypte Appoints New CEO
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Calypte Biomedical Corporation, Key Facts
Calypte Biomedical Corporation Pipeline Products and Clinical Trials Overview
Calypte Biomedical Corporation Pipeline Products by Equipment Type
Calypte Biomedical Corporation Pipeline Products by Indication
Calypte Biomedical Corporation, Key Facts
Calypte Biomedical Corporation, Major Products and Services
Calypte Biomedical Corporation Number of Pipeline Products by Development Stage
Calypte Biomedical Corporation Pipeline Products Summary by Development Stage
Aware - Syphilis Assay - Product Status
Aware - Syphilis Assay - Product Description
Aware 2 HIV-1/2 - Product Status
Aware 2 HIV-1/2 - Product Description
Aware HIV-1/2 OMT - Product Status
Aware HIV-1/2 OMT - Product Description
Second Generation Incidence Test - HIV-1 - Product Status
Second Generation Incidence Test - HIV-1 - Product Description
Calypte Biomedical Corporation, Key Employees
Calypte Biomedical Corporation, Other Locations

LIST OF FIGURES

Calypte Biomedical Corporation Pipeline Products by Equipment Type
Calypte Biomedical Corporation Pipeline Products by Development Stage
Skip to top


Ask Your Question

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: